Literature DB >> 15804959

A case of a progressive multifocal leukoencephalopathy patient with four different JC virus transcriptional control region rearrangements in cerebrospinal fluid, blood, serum, and urine.

Serena Delbue1, Giovanni Sotgiu, Daniela Fumagalli, Marilena Valli, Elisa Borghi, Roberta Mancuso, Enrico Marchioni, Renato Maserati, Pasquale Ferrante.   

Abstract

JC virus (JCV) is the etiological agent of progressive multifocal leukoencephalopathy (PML), a fatal demyelinating disease of the central nervous system (CNS). During the acquired immunodeficiency syndrome (AIDS) epidemic, it was the cause of the death in up to 8% of AIDS patients. The genomic organization of JCV and, in particular, the hypervariability of the transcriptional control region (TCR), a regulatory noncoding region, are well known. Given that the TCR plays a central role in the viral replication of JCV, a crucial role in the determination of the neurotropism and in the pathogenic capabilities of the virus is also suspected. Here the authors describe a case of PML that did not respond to highly active antiretroviral therapy (HAART) therapy. There was a simultaneous presence of JCV strains with four different TCR structures in urine, peripheral blood cells, serum, and cerebrospinal fluid (CSF) samples. These data confirmed that the presence of the archetype TCt is restricted to urine, while also suggesting that the degree of the rearrangement varies and increases from the peripheral blood to CSF.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15804959     DOI: 10.1080/13550280590900382

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  27 in total

1.  Increased frequency of JC virus type 2 and of dual infection with JC virus type 1 and 2 in Italian progressive multifocal leukoencephalopathy patients.

Authors:  P Ferrante; M Mediati; R Caldarelli-Stefano; L Losciale; R Mancuso; A E Cagni; R Maserati
Journal:  J Neurovirol       Date:  2001-02       Impact factor: 2.643

2.  Adjacent nuclear factor-1 and activator protein binding sites in the enhancer of the neurotropic JC virus. A common characteristic of many brain-specific genes.

Authors:  K Amemiya; R Traub; L Durham; E O Major
Journal:  J Biol Chem       Date:  1992-07-15       Impact factor: 5.157

Review 3.  Progressive multifocal leukoencephalopathy.

Authors:  J R Berger; E O Major
Journal:  Semin Neurol       Date:  1999       Impact factor: 3.420

4.  Human polyomavirus JC control region variants in persistently infected CNS and kidney tissue.

Authors:  C Elsner; K Dörries
Journal:  J Gen Virol       Date:  1998-04       Impact factor: 3.891

5.  Analysis of transcription control elements of the mouse myelin basic protein gene in HeLa cell extracts: demonstration of a strong NFI-binding motif in the upstream region.

Authors:  T Tamura; M Miura; K Ikenaka; K Mikoshiba
Journal:  Nucleic Acids Res       Date:  1988-12-23       Impact factor: 16.971

6.  Human polyomavirus JC virus genome.

Authors:  R J Frisque; G L Bream; M T Cannella
Journal:  J Virol       Date:  1984-08       Impact factor: 5.103

7.  Human polyomavirus JC promoter/enhancer rearrangement patterns from progressive multifocal leukoencephalopathy brain are unique derivatives of a single archetypal structure.

Authors:  G S Ault; G L Stoner
Journal:  J Gen Virol       Date:  1993-08       Impact factor: 3.891

8.  Brain and kidney of progressive multifocal leukoencephalopathy patients contain identical rearrangements of the JC virus promoter/enhancer.

Authors:  G S Ault; G L Stoner
Journal:  J Med Virol       Date:  1994-11       Impact factor: 2.327

9.  PCR detection of JC virus DNA in brain tissue from patients with and without progressive multifocal leukoencephalopathy.

Authors:  P Ferrante; R Caldarelli-Stefano; E Omodeo-Zorini; L Vago; R Boldorini; G Costanzi
Journal:  J Med Virol       Date:  1995-11       Impact factor: 2.327

10.  Rearrangement patterns of JC virus noncoding control region from different biological samples.

Authors:  V Pietropaolo; M Videtta; D Fioriti; M Mischitelli; A Arancio; N Orsi; A M Degener
Journal:  J Neurovirol       Date:  2003-12       Impact factor: 2.643

View more
  23 in total

1.  JC virus promoter/enhancers contain TATA box-associated Spi-B-binding sites that support early viral gene expression in primary astrocytes.

Authors:  Leslie J Marshall; Lisa D Moore; Matthew M Mirsky; Eugene O Major
Journal:  J Gen Virol       Date:  2011-11-09       Impact factor: 3.891

2.  Presence and expression of JCV early gene large T Antigen in the brains of immunocompromised and immunocompetent individuals.

Authors:  Serena Delbue; Emanuela Branchetti; Renzo Boldorini; Luca Vago; Pietro Zerbi; Claudia Veggiani; Sara Tremolada; Pasquale Ferrante
Journal:  J Med Virol       Date:  2008-12       Impact factor: 2.327

3.  First identification and molecular characterization of lymphotropic polyomavirus in peripheral blood from patients with leukoencephalopathies.

Authors:  Serena Delbue; Sara Tremolada; Emanuela Branchetti; Francesca Elia; Elisa Gualco; Enrico Marchioni; Renato Maserati; Pasquale Ferrante
Journal:  J Clin Microbiol       Date:  2008-05-14       Impact factor: 5.948

4.  Rearranged JC virus noncoding control regions found in progressive multifocal leukoencephalopathy patient samples increase virus early gene expression and replication rate.

Authors:  Rainer Gosert; Piotr Kardas; Eugene O Major; Hans H Hirsch
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

Review 5.  Pathogenesis of progressive multifocal leukoencephalopathy--revisited.

Authors:  Martyn K White; Kamel Khalili
Journal:  J Infect Dis       Date:  2011-01-12       Impact factor: 5.226

6.  JC virus infection is acquired very early in life: evidence from a longitudinal serological study.

Authors:  Francesca Elia; Sonia Villani; Federico Ambrogi; Lucia Signorini; Simone Dallari; Sandro Binda; Valeria Primache; Laura Pellegrinelli; Pasquale Ferrante; Serena Delbue
Journal:  J Neurovirol       Date:  2016-08-18       Impact factor: 2.643

7.  JC virus VP1 loop-specific polymorphisms are associated with favorable prognosis for progressive multifocal leukoencephalopathy.

Authors:  Serena Delbue; Emanuela Branchetti; Simone Bertolacci; Eleonora Tavazzi; Enrico Marchioni; Renato Maserati; Giulia Minnucci; Sara Tremolada; GianLuca Vago; Pasquale Ferrante
Journal:  J Neurovirol       Date:  2008-11-27       Impact factor: 2.643

8.  JC virus viremia in interferon-beta -treated and untreated Italian multiple sclerosis patients and healthy controls.

Authors:  Serena Delbue; Franca Rosa Guerini; Roberta Mancuso; Domenico Caputo; Romina Mazziotti; Marina Saresella; Pasquale Ferrante
Journal:  J Neurovirol       Date:  2007       Impact factor: 2.643

9.  JC virus urinary excretion and seroprevalence in natalizumab-treated multiple sclerosis patients.

Authors:  Serena Delbue; Francesca Elia; Camilla Carloni; Valentina Pecchenini; Diego Franciotta; Matteo Gastaldi; Elena Colombo; Lucia Signorini; Silvia Carluccio; Anna Bellizzi; Roberto Bergamaschi; Pasquale Ferrante
Journal:  J Neurovirol       Date:  2014-07-23       Impact factor: 2.643

10.  DNA-binding transcription factor NF-1A negatively regulates JC virus multiplication.

Authors:  Veerasamy Ravichandran; Eugene O Major
Journal:  J Gen Virol       Date:  2008-06       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.